Fredericksburg boy who received experimental drug after battle with drug company heading home
MEMPHIS, Tenn. – Josh Hardy, the 7-year-old boy whose parents fought to get him an experimental drug, is headed home.
Josh’s mother, Aimee, posted on the SaveJosh Facebook page Wednesday morning that the family is headed home to Fredericksburg after spending six and a half months receiving treatment at St. Jude Children’s Research Hospital in Memphis.
“Glory to GOD! We are going home!!!! Leaving today. After 6 1/2 months, Josh finally gets to be in his house,” Aimee Hardy wrote.
“His lung function is perfect. His tummy is coming around. He has not had the need of a blood transfusion in a month,” Aimee Hardy wrote. “And with a lot of hard work his strength will return. He can walk a nice distance holding my hands. And we anticipate the return of his immunity in a few months.”
Josh gained national attention after his family petitioned the North Carolina-based drug maker Chimerix to allow him to be treated with the experimental drug. He contracted a rare virus when his immune system was compromised during a life-saving bone marrow transplant.
- After near-death experience, check out what this amazing kid can do now
- Josh Hardy’s father says son faces ‘long road to recovery’
- UPDATE: Company says ailing 7-year-old will get drug as part of study